Immunoregulatory treatment for minimal change nephrotic syndrome.
D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D009402:Nephrosis, Lipoid / Q000188:drug therapy*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects
D007978:Levamisole